New Hospitalization Numbers Show Devastating Danger from COVID Shots

Image: Vaccine Immunologists Starting to Resemble the Academy of Projectors in Gulliver’s Travels

Related: Clear Evidence of Vital Immune Evasion, Immune Prejudicing, Original Antigenic Sin

• Ivermectin Efficacy Finally Proven In ‘Gold-Standard’ RCT

• Birx Openly Admits To Lying About The Covid Vaccines To Manipulate The American People

• Forgiving the Medically Brainwashed in the Post-COVID Era

• Justin Trudeau Called A Tyrant As He Is Swarmed By Angry Mandate Protesters

Video: Dan Bongino Show Clips

• Sen. Johnson Calls For Congress to Investigate Vaccine Manufacturers and Covid Vax Approval Process in Response to Project Veritas’ Exposé on Pfizer
• Judge Issues Preliminary Injunction Blocking Newsom’s Covid ‘Misinformation’ Law

• Former NFL Player Jessie Lemonier Dies Suddenly at 25
• 18-Year-Old Freshman Dies Suddenly After Collapsing During Workout
• “Safe & Effective Vaccine” caused ER Nurse to have a Heart Attack
• Federal judge suspends enforcement of new California law targeting docs that provide Covid ‘misinformation’

• Covid 3 Years Later and the Truth Is Still Not Known as to its Origin
• Fauci’s SHADY Gain of Function Research!
• The Deceptive Campaign for Bivalent Covid Boosters

• The Ethical and Religious Implications of Covid-19
• American public calls for safety check on Covid vaccines
• Yeadon and Rees on ‘The End Game’ for mRNA Gene Therapy Vaccines

• FAA Change Triggers Worries Over Pilot Health, Public Safety
• That’s Science? Congress Must Probe The Rationale For COVID Mask Mandates

Luvox (fluvoxamine): Too Dangerous to Treat COVID

There have been recommendations for using Luvox (fluvoxamine) for the treatment of COVID.¹ Years ago, it became apparent to me that fluvoxamine was the most dangerous SSRI antidepressant, causing high rates of mania and psychosis, and incidents of suicide and violence. In 2002, I wrote a report about Luvox for the International Journal of Risk & Safety in Medicine,²whereI marshaled considerable evidence for its dangerous array of adverse psychiatric events. I also summarized a single case report from the literature:

A single case study of a 17-year-old youngster taking fluvoxamine provides a window into what happened to Eric Harris.³ The youth, in this case, was mildly retarded when he became depressed and anxious and was started on a 50 mg dose of fluvoxamine. After a single dose, he developed “increasing agitation and insomnia.” Then, “In the next 24 hours, he displayed auditory and visual hallucinations, a fearful mood, and paranoid delusions involving statements that ‘the devil will get me’”. He required hospitalization and was treated with antipsychotic drugs.

Although fluvoxamine in the treatment of COVID-19 is recommended for only ten days, that relatively short period may not prevent its worst adverse psychiatric effects, which often occur early in treatment, as well as during changes of doses.⁴

Full article ..

• Judge trashes state law punishing doctors for COVID ‘misinformation’
• We are all playing Covid roulette. Without clean air, the next infection could permanently disable you
• “COVID-19 Vaccines Are Not Associated with Sudden Death” – FDA Response to an American’s Concerns About COVID Vaccines